Cathie Wood shells out $1.3 million on biotech stock
Affected assets and topics
Why it matters
Cathie Wood, a prominent investor, has invested $1.3 million in Intellia Therapeutics, a biotech company, by purchasing 145,153 shares. This move comes despite the company's forgettable year, with its stock closing in the negative. The investment may indicate a positive outlook for the company's future prospects.
Article tone
Expected market reaction
Market impact analysis based on bullish sentiment with 80% confidence.
Evidence trail
Evidence
AI provenance
Technical identifiers
- Provider tag
- groq-llama-3.1-8b-instant
- Analysis version
- groq-llama-3.1-8b-instant
- Article id
- 27711
Original source
On the final trading day of 2025, Cathie Wood put an eye-brow raising $1.33 million to work in Intellia Therapeutics (NTLA), scooping up 145,153 shares in the gene-editing play. For the most part, it has been a forgettable year for Intellia stock, closing out another year in the negative. The ...
Read the full article on Yahoo Finance
Original article published by Yahoo Finance on December 31, 2025. Analysis and insights provided by AnalystMarkets AI.